Key Decisions and Approvals

The Board of Directors meeting, which commenced at 5:55 PM and concluded at 6:25 PM, approved and took on record the following matter:

1. The Un-audited Financial Results (Standalone) of the Company for the First Quarter and three months ended June 30, 2026, of the Current Financial Year 2026-27 as recommended by the Audit Committee, along with the Limited Review Report of the Statutory Auditors, M/S. MGSA & COMPANY, Chartered Accountants, Bikaner.

Financial Results (Standalone) for Quarter Ended June 30, 2026

(Rupees in Lacs)

Income Statement:

  • Revenue From Operations: ₹65.40
  • Total Income from Operation: ₹65.40
  • Total Expenses: ₹102.39
  • Cost of materials consumed: ₹12.04
  • Changes in inventories: ₹20.29
  • Employee benefits expense: ₹41.76
  • Finance costs: ₹0.22
  • Depreciation and amortization expense: ₹3.56
  • Other expenses: ₹24.52
  • Loss before tax: ₹(36.99)
  • Tax expense: ₹(4.92)
  • Current tax: ₹(4.92)
  • Loss for the period from continuing operations: ₹(32.06)
  • Other Comprehensive Income (Net of Tax): ₹(12.04)
  • Total Comprehensive Income: ₹(44.11)

Comparative Figures:

  • Quarter Ended March 31, 2026 (Audited): Profit of ₹33.77
  • Quarter Ended June 30, 2025 (Unaudited): Loss of ₹(20.81)
  • Year Ended March 31, 2026 (Audited): Profit of ₹4.36

Earnings Per Share (Face Value: ₹10 each):

  • Basic EPS (for continuing operations): -₹18.00
  • Diluted EPS (for continuing operations): -₹18.00

Paid-up Equity Share Capital: 2.45 lakh shares

Auditor's Review Report

The statutory auditors, MGSA & COMPANY, issued a limited review report stating that based on their review, nothing has come to their attention that causes them to believe that the financial results contain any material misstatement. The review was conducted in accordance with Standard on Review Engagements (SRE) 2410 issued by ICAI.

Trading Window Closure

In terms of the Company's internal Code of Conduct read with SEBI (Prohibition of Insider Trading) Regulations, the window for trading in Securities of the Company by Designated Persons will open on Monday, August 17, 2026 (as August 16, 2026, is a Sunday).

Additional Information

  • The financial results have been prepared in accordance with Indian Accounting Standard (Ind-AS) prescribed under Section 133 of the Companies Act, 2013
  • No investor complaints remain pending as of June 30, 2026
  • The results are available on the Company's website (https://wardwizardhealthcare.com) and BSE Limited's website
  • Corporate Identification Number (CIN): L17120MH1985PLC034972
  • Corporate Office: 11, Windward Business Park, Opp. Aadicura Hospital, Jetalpura Road, Vadodara, Gujarat - 390 007